INTERACTIVE DEVICES

DCL Health optimizes price and performance through the deployment of MyHeart app on Android and IOS platforms. We promote the use of mini-tablets as

opposed to full size tablets or smartphones. Mini-tablets blend the ease of handling with a screen that is large enough to address patients with limited dexterity and vision challenges.

Our BioLink software will run on a wide range of Android and IOS devices, and collects all the BLE device data from FDA approved devices and uploads

to the DCL cloud. The list of current tablets that DCL has certified includes:

1. Digiland DL718M Quad Core 8 GB IPS Multi-Touch tablet: Android
2. Samsung Galaxy Tab A 8″ APQ 8016 16 GB 1.5 GB RAM: Android
3. Nexus 5x 16 GB: Android